|
KMG Chemicals Corporate Offices 9555 W. Sam Houston Parkway South Suite 600 Houston, TX 77099 |
| Investor Relations | Company Overview | KMG Electronic Chemicals | KMG-Bernuth | Home |  |
|
KMG Chemicals Reports Fourth Quarter and 2008 Year End ResultsFiscal Year 2008 Revenues up 79% to $154 Million Forecasts Fiscal 2009 Revenues of $200 Million Along with Significantly Improved Profitability HOUSTON--(BUSINESS WIRE)-- KMG Chemicals, Inc. (NASDAQ: KMGB), a global provider of specialty chemicals in niche markets, today announced financial results for the fiscal fourth quarter and year ended July 31, 2008. Effective December 31, 2007, five months into KMG’s fiscal year, the Company acquired an Electronic Chemicals business whose results are included as of the date of acquisition. For the fourth quarter ended July 31, 2008, net sales were $51.4 million, resulting in $2.0 million of operating income, $1.2 million in income from continuing operations before income taxes, net income of $571,000 and diluted EPS from continuing operations of $0.05. In the prior fiscal year period, net sales were $23.6 million, resulting in operating income of $3.4 million, $3.3 million in income from continuing operations before income taxes, net income of $2.0 million and diluted EPS from continuing operations of $0.18. Of the $51.4 million in net sales in the final quarter of fiscal 2008, Animal Health contributed $3.2 million, Wood Treating contributed $21.7 million and Electronic Chemicals contributed $26.4 million. In the fourth quarter of fiscal 2007, Animal Health generated net sales of $3.7 million and Wood Treating generated $19.9 million respectively. For fiscal 2008, the Company reported net sales of $154.4 million, a 79% increase over fiscal 2007, primarily due to its Electronic Chemicals acquisition and strong sales in its Creosote segment. Net income from continuing operations was $5.7 million or $0.50 per diluted share compared to $9.2 million or $0.83 per diluted share in fiscal 2007. Net income for fiscal 2008 was $5.4 million compared to $8.8 million in fiscal 2007. The decline in profitability was primarily due to a sales shortfall in two high margin product lines, Animal Health and Penta, along with a dramatic increase in the cost of a Penta raw material. The shortfall in revenues for each segment occurred primarily in the third fiscal quarter. Of note, in the first quarter of fiscal year 2008, the Company discontinued operations of its herbicide product line (MSMA), which had comprised its agricultural chemical segment. Segment Overview As previously reported, in the second half of fiscal 2008, demand for Animal Health pesticides, particularly high margin ear tag products, was down significantly due to a number of factors, including the delay in the onslaught of the fly season due to unseasonably cool spring weather in key markets, coupled with higher feed, fuel and fertilizer prices, which curtailed discretionary purchases by cattle growers. As a result, Animal Health sales were $11.7 million in fiscal 2008 compared to $14.1 million in the prior fiscal year. Commenting on its Animal Health business, Neal Butler, President and CEO of KMG, stated, “Despite the severe downturn in the market during fiscal 2008, the segment still contributed over $1 million to operating income. We are convinced that Animal Health is a sound market, and we expect to achieve more normalized sales levels domestically in the new fiscal year. To diversify our customer base and minimize the seasonality of this business, we are moving aggressively to penetrate Latin American markets. We have received registrations in Puerto Rico, Mexico and Argentina, and initial shipments have been made to all three countries, with shipments to Mexico and Argentina occurring in the first quarter of fiscal 2009. We have also applied for registrations in Colombia, Venezuela and Brazil and still others are planned. We have targeted the Latin America market, not only because of its large cattle populations, but also because these countries have either year-round warm weather or are situated below the equator so their seasons are opposite those in the northern hemisphere.” KMG’s Penta revenues were well ahead of the prior year throughout the first half; however, Penta revenues in the third fiscal quarter of 2008 were substantially lower than the previous year. The 25% decline in third quarter Penta sales was due to a sharp price increase for #2 oil, which wood treaters use to blend with Penta to treat poles. Penta revenues were $26.4 million for all of fiscal 2008, down 7% from $28.4 million in fiscal 2007. A 35% increase in the cost of a key petroleum-based component resulted in higher unit costs and lower gross margins for our main Penta product. Penta operating profits declined $2.5 million for the year primarily due to the dramatic cost increase for that one component combined with the 7% decline in annual revenues. For fiscal 2008, Creosote sales volumes were consistent with fiscal 2007 and revenues increased more than 26.5% to $55.2 million, from $43.6 million in fiscal 2007, due to price increases implemented by KMG in fiscal 2008 offsetting the rising cost of purchased Creosote. The price increases resulted in a $300,000 increase in operating profits for the segment, despite an increase in certain operating expenses. Mr. Butler pointed out, “In the fourth quarter, we saw Penta sales recover close to fourth quarter 2007 levels. Based on current market intelligence, we believe that fiscal 2009 sales of Creosote and Penta should approximate those of fiscal 2008. We are however mindful of a possible slowdown in business stemming from cash and credit constraints of our customers, higher energy and raw materials costs, and weakness in general economic conditions throughout North America, all of which could negatively influence utility pole replacement and railroad maintenance programs.” KMG’s Electronic Chemicals acquisition from Air Products and Chemicals, Inc. has performed well. The Electronic Chemicals business has grown sales from approximately $91 million during Air Products’ previous fiscal year, to its current annualized run rate of $105 million under KMG’s ownership, representing a more than 15% increase. Electronic Chemicals contributed $2.1 million in operating income in fiscal 2008. The business was operated under a transitional services agreement with the seller through September 2008. Accordingly, 2008 results were adversely impacted by the cost of that agreement with Air Products. The incremental cost of operating under the transitional services was estimated to be $1.2 million for fiscal 2008. Additionally, $670,000 of
third-party consulting fees were incurred to integrate the
acquired business into KMG’s operations and systems. Balance Sheet Discussion John V. Sobchak, CFO of KMG, commented, “Turning to our balance sheet, we closed the year with working capital of $31.0 million, long-term debt (including the current portion) of $61.0 million, and shareholders’ equity of $63.7 million. Using cash flow from operations, we repaid $9.0 million of principal on the debt outstanding at the time we acquired the Electronic Chemicals business, including $3.8 million of the $9 million drawn on our revolver when the transaction closed, and finished the year with $2.6 million in cash. At year-end, we had $29.8 million of unused borrowing capacity on our revolver. Reduction of revolver borrowings during the last seven months was lower than anticipated due to the weakness in Animal Health sales in the second half of the year and the fact that the transitional services with Air Products extended through September.” Looking Forward Summing up, Mr. Butler
noted, “Earnings per share closed almost 40% below 2007, and
neither I nor anyone in the KMG organization is satisfied
with that result. Market factors mentioned above were
responsible for a decreased demand for several key products
which is one reason for our diversification efforts to
aggressively expand into a new market sector and into new
areas of the globe. As we have stated previously, we expect
fiscal 2009 net sales in excess of $200 million and a
significantly improved profit picture. In addition to the
cost savings mentioned earlier in connection with the
Electronic Chemicals business, we will see a $1.2 million
reduction in amortization expense associated with certain
intangible assets, primarily attributable to the June 2005
Penta acquisition. The reduction in amortization expense
will begin in January 2009. We’ve also taken important
measures to offset rising raw material costs by implementing
price increases for our Wood Treating and Electronic
Chemicals products, especially those tied to rising
petroleum prices. Lastly, we see our expansion into the
Latin American market for our Animal Health products as a
key growth driver.” These upgrades in IT, human resource management, process controls, and management bench strength, not only support the far larger organization we have become, but should also produce integration efficiencies for future acquisitions. We continue to focus on internal growth where possible, making those businesses more efficient and productive while exploring additional stable chemical product lines in the Animal Health and Electronic Chemicals segments. We continue to search for businesses that have significant market positions and would be accretive to our cash flow and earnings. The current economic situation should present additional acquisition opportunities at very attractive multiples. We will use fiscal 2009 to prepare the way for our next acquisition, which we look to consummate in fiscal 2010. In the meantime, we will use cash flow from operations to pay down debt and reload our balance sheet.” Conference Call Messrs. Butler and Sobchak will conduct a conference call focusing on the financial results at 10:00 a.m. ET today, Monday, October 13, 2008. Interested parties may participate in the call by dialing 866-861-6730. Please call in 10 minutes before the call is scheduled to begin, and ask for the KMGB call. The conference call will also be webcast live via the Investor Relations section of KMG’s website at www.kmgchemicals.com. To listen to the live call please go to the website at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the website. About KMG The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, the impact of competitive services and pricing and general economic risks and uncertainties. KMG Chemicals, Inc. Consolidated Statements of Income (In thousands, except per share data) (UNAUDITED)
Balance Sheet Highlights (In thousands) (UNAUDITED)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |